Trends and Correlation Between Antimicrobial Resistance and Antibiotics Consumption in a Specialist Children’s Hospital from 2016 to 2021

References

• Tacconelli E, Sifakis F, Harbarth S, et al. Surveillance for control of antimicrobial resistance. Lancet Infect Dis. 2018;18(3):e99–e106. doi:10.1016/s1473-3099(17)30485-1
   Web of Science ®Google Scholar
• Alawi MM, Darwesh BM. A stepwise introduction of a successful antimicrobial stewardship program. Experience from a tertiary care university hospital in Western, Saudi Arabia. Saudi Med J. 2016;37(12):1350–1358. doi:10.15537/smj.2016.12.15739
   PubMed Web of Science ®Google Scholar
• Fu P, Leiyan H, Wang C, et al. Antimicrobial resistance profile of clinical isolates in pediatric hospitals in China: report from the ISPED Surveillance Program in 2019. Chin J Evid Based Pediatr. 2021;16(01):43–49. doi:10.3969/j.issn.1673-5501.2021.01.002
   Google Scholar
• Enane LA, Christenson JC. Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens. Paediatr Int Child Health. 2021;41(1):65–75. doi:10.1080/20469047.2020.1853350
   PubMed Web of Science ®Google Scholar
• Hu F, Wang M, Zhu D, Wang F. CHINET efforts to control antimicrobial resistance in China. J Glob Antimicrob Resist. 2020;21:76–77. doi:10.1016/j.jgar.2020.03.007
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi:10.1016/s1473-3099(13)70318-9
   PubMed Web of Science ®Google Scholar
• Wushouer H, Zhang ZX, Wang JH, et al. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: based on a 3 year surveillance data, 2014–2016. J Infect Public Health. 2018;11(3):339–346. doi:10.1016/j.jiph.2017.09.021
   PubMed Web of Science ®Google Scholar
• Liang C, Zhang X, Zhou L, Meng G, Zhong L, Peng P. Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019. BMC Infect Dis. 2021;21(1):444. doi:10.1186/s12879-021-06140-5
   PubMed Web of Science ®Google Scholar
• Zeng S, Xu Z, Wang X, et al. Time series analysis of antibacterial usage and bacterial resistance in China: observations from a tertiary hospital from 2014 to 2018. Infect Drug Resist. 2019;12:2683–2691. doi:10.2147/idr.S220183
   Web of Science ®Google Scholar
• Zou YM, Ma Y, Liu JH, et al. Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009–2013). Eur J Clin Microbiol Infect Dis. 2015;34(4):795–803. doi:10.1007/s10096-014-2293-6
   Web of Science ®Google Scholar
• Bronzwaer SL, Cars O, Buchholz U, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8(3):278–282. doi:10.3201/eid0803.010192
   PubMed Web of Science ®Google Scholar
• Mutnick AH, Rhomberg PR, Sader HS, Jones RN. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001). J Antimicrob Chemother. 2004;53(2):290–296. doi:10.1093/jac/dkh039
   Web of Science ®Google Scholar
• Yang P, Chen Y, Jiang S, Shen P, Lu X, Xiao Y. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrob Resist Infect Control. 2018;7:137. doi:10.1186/s13756-018-0430-1
   PubMed Web of Science ®Google Scholar
• Lepper PM, Grusa E, Reichl H, Högel J, Trautmann M. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2002;46(9):2920–2925. doi:10.1128/aac.46.9.2920-2925.2002
   PubMed Web of Science ®Google Scholar
• Wang H, Wang H, Yu X, et al. Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010–2016: a retrospective observational study. BMJ Open. 2019;9(8):e026072. doi:10.1136/bmjopen-2018-026072
   PubMed Web of Science ®Google Scholar
• Baditoiu L, Axente C, Lungeanu D, et al. Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis. Ann Clin Microbiol Antimicrob. 2017;16(1):71. doi:10.1186/s12941-017-0251-8
   PubMed Web of Science ®Google Scholar
• Mladenovic-Antic S, Kocic B, Velickovic-Radovanovic R, et al. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study. J Clin Pharm Ther. 2016;41(5):532–537. doi:10.1111/jcpt.12432
   PubMed Web of Science ®Google Scholar
• Guidelines for atc classification and ddd assignment 23rd edition (2020); 2020. Available from: https://www.whocc.no/atc_ddd_index/. Accessed September 15, 2022.
   Google Scholar
• Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol. 2020;58(3). doi:10.1128/jcm.01864-19
   Web of Science ®Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–E3470. doi:10.1073/pnas.1717295115
   PubMed Web of Science ®Google Scholar
• Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750. doi:10.1016/s1473-3099(14)70780-7
   PubMed Web of Science ®Google Scholar
• Fu P, Wang C, Yu H, et al. Antimicrobial resistance profile of clinical isolates in pediatric hospitals in China: report from the ISPED Surveillance Program, 2017. Chin J Evid Based Pediatr. 2018;13(06):406–411. doi:10.3969/j.issn.1673-5501.2018.06.002
   Google Scholar
• Fu P, Wang C, Yu H, et al. Antimicrobial resistance profile of clinical isolates in pediatric hospitals in China: report from the ISPED Surveillance Program, 2018. Chin J Evid Based Pediatr. 2019;14(05):321–326. doi:10.3969/j.issn.1673-5501.2019.05.001
   Google Scholar
• Leiyan H, Fu P, Xia W, et al. Antimicrobial resistance profile of clinical stains isolated from children in China: a report from the ISPED Program of 2020. Chin J Evid Based Pediatr. 2021;16(06):414–420. doi:10.3969/j.issn.1673-5501.2021.06.002
   Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-1
   PubMed Web of Science ®Google Scholar
• Resistance reported from China antimicrobial surveillance network (CHINET) in 2021; 2022. Available from: https://www.chinets.com/Data/AntibioticDrugFast. Accessed September 15, 2022.
   Google Scholar
• Hu FP, Guo Y, Zhu DM, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin Microbiol Infect. 2016;22(Suppl 1):S9–S14. doi:10.1016/j.cmi.2016.01.001
   PubMed Web of Science ®Google Scholar
• Kim YA, Park YS, Youk T, Lee H, Lee K. Abrupt increase in rate of imipenem resistance in acinetobacter baumannii complex strains isolated from general hospitals in Korea and correlation with carbapenem administration during 2002–2013. Ann Lab Med. 2018;38(2):179–181. doi:10.3343/alm.2018.38.2.179
   Web of Science ®Google Scholar
• Abdallah M, Badawi M, Alzaagi I, Issa KN, Rasheed A, Alharthy A. Effect of short-term carbapenem restriction on the incidence of non-pseudomonal multi-drug resistant Gram-negative bacilli in an intensive care unit. J Chemother. 2019;31(5):261–266. doi:10.1080/1120009x.2019.1601802
   PubMed Web of Science ®Google Scholar
• Zhou Y, Jia X, He J, Xia Y. Study on clinical characteristics and risk factors for infection of Imipenem-heteroresistant Enterobacter cloacae. Chin Med Herald. 2019;16(16):147–150.
   Google Scholar
• Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect. 2006;43(Suppl 2):S100–S105. doi:10.1086/504487
   PubMed Web of Science ®Google Scholar
• Avila-Novoa MG, Solís-Velázquez OA, Rangel-López DE, González-Gómez JP, Guerrero-Medina PJ, Gutiérrez-Lomelí M. Biofilm formation and detection of fluoroquinolone- and carbapenem-resistant genes in multidrug-resistant acinetobacter baumannii. Can J Infect Dis Med Microbiol. 2019;2019:3454907. doi:10.1155/2019/3454907
   Web of Science ®Google Scholar
• Donadu MG, Mazzarello V, Cappuccinelli P, et al. Relationship between the biofilm-forming capacity and antimicrobial resistance in clinical acinetobacter baumannii isolates: results from a laboratory-based in vitro study. Microorganisms. 2021;9(11). doi:10.3390/microorganisms9112384
   Web of Science ®Google Scholar
• Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011;34(9):737–751. doi:10.5301/ijao.5000027
   PubMed Web of Science ®Google Scholar
• Yuksel FN, Karatug NT, Akcelik M. Does subinhibitory concentrations of clinically important antibiotic induce biofilm production of Enterococcus faecium strains? Acta Microbiol Immunol Hung. 2018;65(1):27–38. doi:10.1556/030.64.2017.041
   Web of Science ®Google Scholar
• Jepsen K, Falk W, Brune F, et al. Prevalence and antibiotic susceptibility trends of selected enterobacteriaceae, enterococci, and candida albicans in the subgingival microbiota of German periodontitis patients: a retrospective surveillance study. Antibiotics. 2022;11(3). doi:10.3390/antibiotics11030385
   Web of Science ®Google Scholar
• McCarthy H, Rudkin JK, Black NS, Gallagher L, O’Neill E, O’Gara JP. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front Cell Infect Microbiol. 2015;5:1. doi:10.3389/fcimb.2015.00001
   PubMed Web of Science ®Google Scholar
• Khasawneh AI, Himsawi N, Abu-Raideh J, et al. Status of biofilm-forming genes among Jordanian nasal carriers of methicillin-sensitive and methicillin-resistant Staphylococcus aureus. Iran Biomed J. 2020;24(6):386–398. doi:10.29252/ibj.24.6.381
   Google Scholar
• Christaki E, Marcou M, Tofarides A. Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence. J Mol Evol. 2020;88(1):26–40. doi:10.1007/s00239-019-09914-3
   PubMed Web of Science ®Google Scholar